Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple-drug Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02475629
What this trial is testing

Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV

Who this might be right for
HIV
TaiMed Biologics Inc. 40
Not applicableUnknownNCT04126304
What this trial is testing

Mycoplasma Infection Rate and Macrolides Resistance in Children With Acute Respiratory Tract Infection

Who this might be right for
Respiratory Tract Infections
Shanghai Children's Medical Center 2,312
Not applicableStudy completedNCT01894347
What this trial is testing

Prospective Observational Pilot-study for the Evaluation of the Nephro- an Neurotoxicity in the Anti-infectious Therapy With Inhalative Colistin Therapy for Patients With Ventilator-associated Pneumonia (VAP)

Who this might be right for
Infection Resistant to Multiple Drugs
Charite University, Berlin, Germany 9
Testing effectiveness (Phase 2)Study completedNCT01068860
What this trial is testing

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Who this might be right for
Type 2 Diabetes MellitusImpaired Glucose Tolerance
Novartis 246
Testing effectiveness (Phase 2)UnknownNCT06539559
What this trial is testing

Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm MetastasisDrug Therapy+1 more
Wang Jiayu 60
Testing effectiveness (Phase 2)Study completedNCT02573350
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Who this might be right for
Tuberculosis, Multidrug-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 213
Not applicableStudy completedNCT03248999
What this trial is testing

Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.

Who this might be right for
Drug Resistance, Bacterial
Centre Hospitalier Universitaire de Besancon 264
Not applicableUnknownNCT04388293
What this trial is testing

Using Antibiotics Wisely - An Antimicrobial Stewardship Program

Who this might be right for
Multi-Drug Resistant OrganismsLate-Onset Sepsis, NeonatalAntimicrobial Resistance
University of British Columbia 2,000
Early research (Phase 1)Study completedNCT00256191
What this trial is testing

Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies

Who this might be right for
NeoplasmsHodgkin's DiseaseNon-Hodgkin's Lymphoma
Cortice Biosciences, Inc. 45
Post-approval studies (Phase 4)Study completedNCT00842127
What this trial is testing

Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Bundang CHA Hospital 150
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Testing effectiveness (Phase 2)Study completedNCT02159066
What this trial is testing

LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma

Who this might be right for
Melanoma
Pfizer 158
Large-scale testing (Phase 3)Active Not RecruitingNCT02362503
What this trial is testing

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

Who this might be right for
HIV Infections
ViiV Healthcare 371
Large-scale testing (Phase 3)Ended earlyNCT01455246
What this trial is testing

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Who this might be right for
CirrhosisAscitesNosocomial Spontaneous Bacterial Peritonitis
University of Padova 32
Not applicableLooking for participantsNCT04172025
What this trial is testing

Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathogens

Who this might be right for
Multiresistant Bacterial PathogensVirulent Bacterial Pathogens
University Hospital, Basel, Switzerland 10,000
Not applicableLooking for participantsNCT06251635
What this trial is testing

Effects of Antipsychotics on Brain Insulin Action in Females

Who this might be right for
Insulin ResistanceMenstrual CycleType 2 Diabetes+1 more
Centre for Addiction and Mental Health 15
Not applicableUnknownNCT06485791
What this trial is testing

Evaluation of the Variation of the Intestinal Microbiota and the Integrity of the Intestinal Barrier in Patients With M.D.R. Germ-induced Pneumonia Undergoing Enteral Nutrition

Who this might be right for
Multi Drug ResistantDysphagia
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 50
Testing effectiveness (Phase 2)Study completedNCT04608955
What this trial is testing

Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081

Who this might be right for
Pulmonary Tuberculosis
Shanghai Jiatan Pharmatech Co., Ltd 99
Testing effectiveness (Phase 2)Study completedNCT00685360
What this trial is testing

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug ResistantExtensively Drug-Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 481
Not applicableStudy completedNCT02198573
What this trial is testing

Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar

Who this might be right for
Day-3 Positive of ParasitaemiaPrevalence of Drug Resistance Gene Mutation
Myat Htut Nyunt 91
Next Page